Hyperthyroidism after propranolol withdrawal.

Classic features of thyrotoxicosis developed in three patients with no prior history of thyroid disease shortly after the discontinuation of therapy with or decrease in doseage of propranolol hydrochloride. Graves' disease probably developed fortuitously after propranolol therapy was instituted, but the beta-adrenergic blockade masked the clinical features of hyperthyroidism. On discontinuation of propranolol therapy or decrease in propranolol dosage, previously latent thyrotoxicosis became manifest. If hyperthyroidism masked by beta-blockade is not recognized before withdrawal of propranolol therapy in patients with ischemic heart disease, the sudden appearance of thyrotoxicosis may lead to symptoms of increased myocardial ischemia.

[1]  G. L. Noel,et al.  Failure of propranolol to alter thyroid iodine release, thyroxine turnover, or the TSH and PRL responses to thyrotropin-releasing hormone in patients with thyrotoxicosis. , 1975, The Journal of clinical endocrinology and metabolism.

[2]  R. Miller,et al.  Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. , 1975, The New England journal of medicine.

[3]  D. Harrison,et al.  Coronary artery syndromes after sudden propranolol withdrawal. , 1974, Annals of internal medicine.

[4]  F. Sundler,et al.  Sympathetic innervation of the mouse thyroid and its significance in thyroid hormone secretion. , 1974, Endocrinology.

[5]  J. Somberg,et al.  Withdrawal of propranolol and myocardial infarction. , 1973, Lancet.

[6]  R. Slome.  Withdrawal of propranolol and myocardial infarction. , 1973, Lancet.

[7]  L. Shenkman,et al.  Rapid simultaneous radioimmunoassay for triiodothyronine and thyroxine in unextracted serum. , 1972, Biochemical and biophysical research communications.

[8]  E. Williams,et al.  Effect of propranolol on serum-thyroxine. , 1970, Lancet.

[9]  M. Nellen.  Trial of two beta blockade drugs, Ciba 39089 and ICI 50172, in angina pectoris. , 1969, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[10]  D. Hadden,et al.  Propranolol and the utilization of radioiodine by the human thyroid gland. , 1969, Acta endocrinologica.

[11]  D. Hadden,et al.  Controlled trial of propranolol in thyrotoxicosis. , 1969, Lancet.

[12]  J. W. Cox,et al.  Combined alpha and beta sympathetic blockade in hyperthyroidism. Clinical and metabolic effects. , 1969, Annals of internal medicine.

[13]  B. Murphy,et al.  DETERMINATION OF THYROXINE UTILIZING THE PROPERTY OF PROTEIN-BINDING. , 1964, The Journal of clinical endocrinology and metabolism.